Company intelligence / Profile preview

Symogen

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Symogen is an international consulting and service provider specializing in pharmacovigilance, medical device vigilance, medical writing, regulatory affairs, and pharmacoepidemiology. The company offers full-scale solutions for pharmacovigilance throughout all phases of clinical trials and post-marketing processes. It leverages advanced technologies such as process automation, machine learning, and big data to enhance efficiency in safety data collection and reporting.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Symogen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Symogen.

Explore the full profile